Evaluation of a Series of Naphthamides as Potent, Orally Active Vascular Endothelial Growth Factor Receptor-2 Tyrosine Kinase Inhibitors
Matthew M. Weiss(Amgen (United States)), Roger Zanon(Amgen (United States)), David Bauer(Amgen (United States)), Michael Schrag(Amgen (United States)), Danlin Chen(Amgen (United States)), Julie Flynn(Amgen (United States)), Juan Estrada(Universidad de Antioquia), Douglas A. Whittington(Amgen (United States)), George Borg(University of Pennsylvania), Andrew S. Tasker(Amgen (United States)), Jean-Christophe Harmange(Amgen (United States)), Anthony Polverino(Amgen (United States)), Deborah M. Choquette(Amgen (United States)), Tom DeMelfi(Amgen (United States)), Charlie Starnes(Amgen (United States)), Michele Potashman(Biogen (United States)), Russell F. Graceffa(Amgen (United States)), Phillip M. Roveto(Amgen (United States)), Shawn Harriman(Amgen (United States)), James Bready(Amgen (United States)), Alexander Long(Amgen (United States)), Vinod F. Patel(Guy's Hospital), Daniel S. La(Amgen (United States)), Nicholas Doerr(Amgen (United States)), Virginia Berry(Amgen (United States)), Kelly Regal(Amgen (United States)), Loren Berry(Amgen (United States)), Yohannes Teffera(Amgen (United States)), Angela Coxon(Amgen (United States)), Stephen A. Kaufman(Amgen (United States)), Sesha Neervannan(Amgen (United States))
Cited by 34
Related Papers
Genetic Evidence for Functional Redundancy of Platelet/Endothelial Cell Adhesion Molecule-1 (PECAM-1): CD31-Deficient Mice Reveal PECAM-1-Dependent and PECAM-1-Independent Functions
|The Journal of Immunology|1999|428
Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score
|The Lancet Neurology|2009|268
Remarkably Stable Tetrahedral Intermediates: Carbinols from Nucleophilic Additions to<i>N</i>���Acylpyrroles
|Angewandte Chemie International Edition|2002|167